Dreyer Scott bought COLL
December 8, 2025 · Form 4 insider transaction
Dreyer Scott bought 17,600 shares of Collegium Pharmaceutical, Inc. at $15.90 per share, a transaction worth $279.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,600
Price
$15.90
Total value
$279.8K
InsiderDreyer Scott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after121,213
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025.